MTE #40 - Metabolic Alterations as Drivers of Progressive Liver Fibrosis and Portal Hypertension
Nov
13
2023
Room 204
-
Hynes Convention Center
7:30
- 8:15 AM EST
Description
The aim is to discuss metabolic alterations that are involved in liver fibrosis and portal hypertension.
Objectives
- Gain an in-depth understanding of the metabolic alterations involved in the progression of liver fibrosis and the development of portal hypertension
- Identify key metabolic pathways and cell types that contribute to the pathogenesis of progressive liver fibrosis and portal hypertension
- Explore potential therapeutic targets and interventions aimed at modulating metabolic dysregulation to mitigate liver fibrosis and portal hypertension progression